Aspectos actuales de la tuberculosis laringea. A propósito de un caso

Dicenta Sousa, M; Doménech Juan, I; Cisa Lluís, E; González Compta, X; Tornero Saltó, J; Nogués Orpí, JJ.
An. otorrinolaringol. Ibero-Am ; 31(2): 159-165, mar.-abr. 2004.
Artículo en Es | IBECS (España) | ID: ibc-32267

Documentos relacionados

  1. Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study.
  2. Optimising pyrazinamide for the treatment of tuberculosis.
  3. Identification and optimization of pyridine carboxamide-based scaffold as a drug lead for <i>Mycobacterium tuberculosis</i>.
  4. Fully weekly antituberculosis regimen: a proof-of-concept study.
  5. [Evaluation of a high-intensity fluorescent fluorophage method for diagnosis of drug-resistance in tuberculosis].
  6. [Current aspects of laryngeal tuberculosis].
  7. Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis.
  8. Variation in Treatment of Pediatric Tuberculosis Infection in Different Provider Settings.
  9. Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection.
  10. Factors Associated With Discontinuation of Tuberculosis Preventive Treatment: Post Hoc Analysis of 2 Randomized, Controlled Trials.